Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Blocking certain brain processes reduces mating behavior in female rats.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

Researchers made new compounds that could potentially be developed into anticancer drugs.

New molecules can prevent cell death in hair follicles.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Different medications can cause serious side effects in some people.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Unregulated glucocorticoid use can disrupt hormone balance and cause serious health issues.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Strontium ranelate is no longer available for treatment.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

Allopregnanolone likely doesn't influence ethanol's rewarding effects in these mice.

Integrating biological networks improves drug repurposing and ADR prediction.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.